HOME >> MEDICINE >> NEWS
Rats Receiving Ginkgo Biloba Learn Quicker, Live 20 Percent Longer Than Controls, UB Study Finds

BUFFALO, N.Y. -- Ginkgo biloba, prescribed widely in Europe to improve brain function, appears to improve learning and memory in rats and prolongs their life, a study at the University at Buffalo has shown.

The unexpected positive effect on longevity has surfaced in research to determine ginkgo biloba's effect on age-related cognitive deficits, using rats as an animal model.

"At a certain point in our analysis, we realized that the rats who were receiving ginkgo biloba were living substantially longer than those who were not receiving the extract," said Jerrold C. Winter, Ph.D., professor of pharmacology and toxicology in UB's School of Medicine and Biomedical Sciences and author of the study.

"That finding leads us to speculate that in addition to ginkgo biloba's purported beneficial effects on brain function, which our study supports, the extract may also have a positive effect on longevity."

Results of the study appear in the current issue of Physiology and Behavior.

Ginkgo biloba is available in the U.S. as a dietary supplement, but is not approved by the FDA as a medical treatment. It is prescribed widely by physicians in Germany and France in the form of EGb 761 -- a complex mixture of chemicals obtained from ginkgo leaves -- to treat age-related deterioration in brain function. Several human trials there have shown positive results, but little research has been done to replicate these findings in animals, Winter said.

Winter's earlier research with rats showed that a set of tasks performed in an apparatus called the radial maze could reliably detect deficiencies in learning and memory related to age. In the current study, Winter used 20-month-old rats, which were assigned a diet that included either ginkgo biloba extract or no extract. Over several weeks, the animals performed tasks in the radial maze that required them to master new challenges and retain learned information over time.

Re
'"/>

Contact: Lois Baker
baker@newsb.buffalo.edu
716-645-2626
University at Buffalo
14-Jan-1998


Page: 1 2

Related medicine news :

1. Patients May Not Be Receiving The Highest Quality Of Care
2. Cure Rate Soars For Some AML Patients Receiving High-Dose Drug
3. Cancer Patients From Deprived Areas of South East England Arent Receiving Optimum Treatment
4. Ginkgo fails important memory test, according to study in JAMA
5. Ginkgo biloba slows cognitive decline in patients with multiple sclerosis
6. Randomized Placebo-Controlled Study On The Effects Of Oral Treatment With GinkgoBiloba Extract In Patients With Erectile Dysfunction
7. The mysteries of the emotions: The Good, Bad, and the Learned
8. Learning to cover up reduces risk of skin cancer
9. Learning skills greatly limits stress for family caregivers, says Stanford study
10. Learn and Serve announcement and call for proposals
11. Learning with a digital brain

Post Your Comments:
(Date:7/22/2014)... A Florida woman has filed a ... the death of her husband was the result of ... Liebhard LLP reports. According to her complaint, which was ... Southern District of Florida on June 23rd, the decedent ... subdural hemorrhage the following June. Despite emergency treatment, his ...
(Date:7/22/2014)... 22, 2014) The American Society of Hematology ... University of California Los Angeles with the 2014 ... iron homeostasis, including the discovery of the iron-regulatory hormone ... This award, named after the Nobel Prize Laureate and ... research achievements in hematology that have represented a paradigm ...
(Date:7/22/2014)... you,re a member of the Clean Plate Club you ... you,re not alone! A new Cornell University study shows ... she puts on his or her plate. "If ... stomach," says Brian Wansink Ph.D., author of the forthcoming book, ... Cornell Food and Brand Lab. , Wansink and co-author Katherine ...
(Date:7/22/2014)... 2014) -- The American Society of Hematology (ASH) will ... Coulter Award for Lifetime Achievement in Hematology, to Kanti ... Jewish (LIJ) School of Medicine for his 50-year career ... and mentoring, and exceptional patient care. , The ... is bestowed on an individual who has been a ...
(Date:7/22/2014)... July 22, 2014 SIMpalm, ... updated payment app for Forte Payment System. Forte Mobile ... ACH payments on iPhone, iPod and iPad. The ... been recently updated by SIMpalm. This update was for ... currently supported on iOS 4.3 and is available to ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
(Date:7/22/2014)... 22, 2014 BiologicTx ® today announced ... 3-way Kidney Paired Donation transplant exchange utilizing BiologicTx,s proprietary ... July 9 at the Miami Transplant Institute, located at ... Kidney Paired Donation (KPD) is ... for kidney transplant with one another due to incompatible ...
(Date:7/22/2014)...  A central New York ... Total Artificial Heart implant is home, discharged from ... Freedom® portable driver to wait for a matching ... from a Syracuse architectural hardware company, suffered from ... medications, an implantable defibrillator and a pacemaker. ...
(Date:7/22/2014)... -- Halozyme Therapeutics, Inc. (NASDAQ: HALO ) today ... patients in its ongoing Phase 2 trial (Study 202) ... revised clinical protocol agreed to with the FDA in ... proprietary recombinant human hyaluronidase under development for the systemic ... "Our diligent effort to rapidly re-initiate patient enrollment and ...
Breaking Medicine Technology:BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3
Cached News: